New Horizons Forum

The 4th Annual New Horizons Forum: speeding the development of new therapies and diagnostics for glaucoma patients.

NHFweb-2015.jpg

February 6, 2015 — San Francisco, California

nh_lee_100.jpg

Keynote Speaker: Paul P. Lee, MD, JD
The Drs. Henry and Frederick Sutro Memorial Lecturer
F. Bruce Fralick Professor and Chair of Ophthalmology and Visual Sciences;
Director, W.K. Kellogg Eye Center, University of Michigan

The centerpiece of Glaucoma 360, the New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.

Launched in 2012 by the Glaucoma Research Foundation, this catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice.

What others are saying about the New Horizons Forum:

"New Horizons is an interdisciplinary meeting and ophthalmologists can learn so much from colleagues with a different perspective. Our ophthalmic community is at its most vibrant when we collaborate and share ideas. New Horizons is where this happens."
- Ruth D. Williams, MD, President, Wheaton Eye Clinic

"The best meeting to learn about what's really new in glaucoma."
- Ahmad A. Aref, MD, Illinois Eye and Ear Infirmary

"A great introduction to emerging technologies together with the opportunity to meet the innovators."
- John Maroney, CEO, ForSight Vision 5

Who should attend:

  • Early-stage company CEOs and executives
  • Business Development and other representatives from companies that offer pharmaceuticals, devices, drug delivery, and IOP monitoring for glaucoma patients
  • Key Opinion Leaders and Leading Ophthalmologists
  • Industry Executives
  • Venture Capitalists
  • Representatives from Clinical Research Organizations
  • Scientific innovators

Leadership

Thumbnail image for graves-2012_200.jpg

Founder and Co-Chair

Adrienne Graves, PhD
Independent Director:
Akorn, TearLab Corporation, Aerpio Therapeutics, and Encore Vision, Inc.

iwach-2012_100.gif

Founder and Co-Chair

Andrew G. Iwach, MD
Executive Director
Glaucoma Center of San Francisco

New Horizons Advisory Board

nh_abelson.jpg

Stuart B. Abelson, MBA
President, Chief Executive Officer, Ora, Inc.

nh_adamis.jpg

Anthony P. Adamis, MD
Vice President, Global Head of Ophthalmology, Genentech, Inc.

nh_chaney.jpg

Paul Chaney
President and CEO, PanOptica, Inc.

nh_cioffi.jpg

George A. Cioffi, MD
Chairman, Department of Ophthalmology
Columbia University College of Physicians and Surgeons

nh_crandall.jpg

Alan Crandall, MD
Director of Glaucoma and Cataract, Senior Vice Chairman of Ophthalmology & Visual Sciences
John A. Moran Eye Center, University of Utah

nh_cunningham.jpg

Emmett Cunningham, Jr., MD, PhD, MPH
Partner, Clarus Ventures

nh_de-juan.jpg

Eugene de Juan, Jr., MD
Founder and Vice-Chairman, ForSight Labs

nh_grunden.jpg

John W. Grunden, PharmD
Regional Director of Medical Affairs for Ophthalmology (USA/EU/Can)
Merck & Co., Inc.

nh_guyer.jpg

David Guyer, MD
Partner, SV Life Sciences Advisers, LLC

higginbotham_100.jpg

Eve Higginbotham, SM, MD
Vice Dean, Perelman School of Medicine, University of Pennsylvania
Co-founder and Director, ROI Squared LLC

nh_hoskins.jpg

H. Dunbar Hoskins, Jr., MD
Co-Founder and Director of Glaucoma Research Foundation, and
Former Executive Vice President, American Academy of Ophthalmology

nh_hutton.jpg

Wende Hutton
General Partner, Canaan Partners

nh_kuschnereit.jpg

Ralf Kuschnereit, PhD
President and Chief Executive Officer, Carl Zeiss Meditec Inc.

nh_lazar.jpg

Eliot Lazar, MD
President, elCON Medical

nh_lee_100.jpg

Paul Lee, MD, JD
F. Bruce Fralick Professor and Chair, Department of Ophthalmology and Visual Sciences and Director, W.K. Kellogg Eye Center, University of Michigan

nh_lindstrom.jpg

Richard Lindstrom, MD
Founder, Minnesota Eye Consultants, PA

nh_link.jpg

William J. Link, PhD
Managing Director, Versant Ventures

nh_markabi.jpg

Sabri Markabi, MD
Sr. Vice President, Research & Development, and Chief Medical Officer
Alcon Laboratories, Inc.

nh_mazzo.jpg

James Mazzo
Operating Partner, Versant Ventures
Chairman and CEO, AcuFocus

mcglynn_100.jpg

J. Casey McGlynn, JD
Partner, Wilson Sonsini Goodrich & Rosati

nh_novack.jpg

Gary D. Novack, PhD
President, PharmaLogic Development, Inc.

nh_pyott.jpg

David E. I. Pyott
Chairman of the Board, President and Chief Executive Officer
Allergan, Inc.

simhambhatla_murthy_100.jpg

Murthy V. Simhambhatla, PhD
President, Abbott Medical Optics
Senior Vice President, Abbott Laboratories

Kuldev Singh

Kuldev Singh, MD, MPH
Professor of Ophthalmology and Director, Glaucoma Service
Stanford University Medical Center

nh_strahlman.jpg

Ellen Strahlman, MD, MHSc
Chief Medical Officer and Senior Vice President, Research & Development,
Becton, Dickinson and Company

Wechsler_100.jpg

Daniel M. Wechsler
Executive Vice President and Company Group Chairman,
Ophthalmology and Eye Health,
Bausch + Lomb

nh_williams_100.jpg

Ruth D. Williams, MD
President, Wheaton Eye Clinic

wilson_100.jpg

M. Roy Wilson, MD
President, Wayne State University

Program

The fourth annual New Horizons Forum, a full-day program, will take place February 6, 2015 in San Francisco.

7:30 AM - Registration, Breakfast, and Exhibits

8:00 AM to 5:30 PM - Program

5:30 PM to 7:00 PM - Reception

New Horizons Exhibit Hall — 7:30 AM to 7:00 PM

Sponsorship Opportunities

For sponsorship opportunities, please contact Aileen Trieu at Glaucoma Research Foundation at (415) 986-3162.

Learn More

For more information, please email Aileen Trieu at Glaucoma Research Foundation, or call (415) 986-3162.

View video testimonials on our Glaucoma 360 Channel.

Proceeds from the New Horizons Forum benefit the Glaucoma Research Foundation for use in our grant-making and other operational priorities.

Last reviewed on March 12, 2014

Was this helpful? Yes No